Replies to post #133139 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Not Just the Common Cold

"The end for the common cold?"

Here's what that paper, in 2009, concluded:

We conclude that the sigma-1 and sigma-2 receptors represent potential fruitful targets for therapeutic developments in combating many human diseases.

Once again, Anavex treatments are not likely to be limited to the few central nervous system diseases presently spotlighted.

[OFP]

The end for the common cold?

If only someone, just once, had taken dextromethorphan when they had a cold. Missed opportunity I guess.